Orion Biotechnology
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
343 Preston St 11TH Fl, Ottawa, Ontario,...Phone Number
(701) 421-3365Website
www.orionbiotechnology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Orion Biotechnology
Orion Biotechnology Canada Ltd, is a privately held pharmaceutical company leveraging advanced receptor pharmacology to develop novel therapies for serious chronic illnesses and life-threatening diseases. The company was founded in 2017 and is headquartered in Ottawa, Ontario, Canada.Explore more
Orion Biotechnology Org Chart
JM
Director of Pharmacology
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Orion Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Orion Biotechnology has new funding data
Congratulate Masked Content for being promoted to Masked Content at Orion Biotechnology
Product Launch: Get notified when Orion Biotechnology launches new products
Check out if Orion Biotechnology is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Orion Biotechnology had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Orion Biotechnology recently announced quarterly report
Check if Orion Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Orion Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Orion Biotechnology as Masked Content
Find 2 more new buyers
Compare Similar Companies to Orion Biotechnology
Compare insights from companies similar to Orion Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Orion Biotechnology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Orion Biotechnology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Orion Biotechnology.
Orion Biotechnology financials insights
Gather financial insights about Orion Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Grant
$1M
Series A
$11.5M
Orion Biotechnology Tech Stack
A closer look at the technologies used by Orion Biotechnology
See more technologies
Most Recent Scoops
Funding
Funding
Funding
Funding
Orion Biotechnology News & Media
Orion Biotechnology Publishes Whitepaper Highlighting the Importance and Challenges in Unlocking “Undruggable” GPCRs
Ottawa, Canada, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs), today announced that it has published a new whitepaper detailing the importance of GPCRs and challenges in unlocking these important but inadequately drugged targets. Available on Fierce Biotech and Dr. GPCR, Orion’s whitepaper reviews the complexities of GPCRs and desOrion Biotechnology Shares In Vivo Efficacy Data on its Latest Best-in-Class Drug Candidate
Ottawa, Canada, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs), today announced that it has obtained positive in vivo data for its CCR2 antagonist, OB-004.Orion Biotechnology to Attend the LSX Investival Showcase and Jefferies Healthcare Conference
Ottawa, Ontario, Canada, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs), today announced that it will be participating in Europe’s biggest dedicated healthcare investment week.Orion Biotechnology to present at 2022 Dr. GPCR Summit Conference
Ottawa, Canada, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs), today announced that it will be presenting at the Dr. GPCR Summit taking place between October 10th and 16th.
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Orion Biotechnology
Sign Up For FreeTo access detailed company insights
Orion Biotechnology Canada Ltd, is a privately held pharmaceutical company leveraging advanced receptor pharmacology to develop novel therapies for serious chronic illnesses and life-threatening diseases. The company was founded in 2017 and is headquartered in Ottawa, Ontario, Canada.... Read More
